CEO, Counterpart Health · CLOVER HEALTH INVESTMENTS, CORP. /DE · Class A Common Stock
Side
SELL
Value
$1.42M
Shares
300.0K
Price
$4.72
Executed
Sep 15, 2026
Disclosed
Sep 16, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Sep 15 executedSep 16, 2026 disclosed
CLOV · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering+15 / 15
3 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Wai Conrad filed this Form 4 reporting a open-market sale of CLOV on Sep 15, 2026. It became public on Sep 16, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CEO, Counterpart Health
Wai Conradcik:0001971702
Issuer
CLOVER HEALTH INVESTMENTS, CORP. /DEcik:0001801170
Revision history · 0
No field has changed since this record was first ingested.
